Status:
COMPLETED
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Post-operative Nausea and Vomiting
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim is to evaluate the effectiveness of three different regimens of prophylactic ondansetron on the incidence and severity of post-operative nausea and vomiting.
Detailed Description
Patients will be randomize to one of three arms: 4mg ondansetron pre-emergence, 8 mg ondansetron pre-emergence, or 4mg ondansetron pre-incision followed by 4mg ondansetron pre-emergence. Primary outco...
Eligibility Criteria
Inclusion
- ASA I, II, III presenting for ambulatory surgery to be performed under general anesthesia
Exclusion
- Patients with allergies or contraindications to study medications
Key Trial Info
Start Date :
October 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2019
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT03297021
Start Date
October 23 2017
End Date
April 5 2019
Last Update
July 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029